217 related articles for article (PubMed ID: 21921084)
21. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.
Auer DP; Pütz B; Kraft E; Lipinski B; Schill J; Holsboer F
Biol Psychiatry; 2000 Feb; 47(4):305-13. PubMed ID: 10686265
[TBL] [Abstract][Full Text] [Related]
22. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
Lin AP; Shic F; Enriquez C; Ross BD
MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
24. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
[TBL] [Abstract][Full Text] [Related]
25. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
[TBL] [Abstract][Full Text] [Related]
26. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
[TBL] [Abstract][Full Text] [Related]
27. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
[TBL] [Abstract][Full Text] [Related]
28. 3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease.
Zou JX; Wang MJ; Lei XJ; Chen XG
Exp Gerontol; 2014 Dec; 60():31-6. PubMed ID: 25220149
[TBL] [Abstract][Full Text] [Related]
29.
Joe E; Medina LD; Ringman JM; O'Neill J
Brain Imaging Behav; 2019 Aug; 13(4):925-932. PubMed ID: 29907927
[No Abstract] [Full Text] [Related]
30. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
31. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
32. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
33. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
[TBL] [Abstract][Full Text] [Related]
34. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
[TBL] [Abstract][Full Text] [Related]
35. Monitoring glutamate levels in the posterior cingulate cortex of thyroid dysfunction patients with TE-averaged PRESS at 3T.
Zhang Q; Bai Z; Gong Y; Liu X; Dai X; Wang S; Liu F
Magn Reson Imaging; 2015 Jul; 33(6):774-8. PubMed ID: 25858622
[TBL] [Abstract][Full Text] [Related]
36. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
[TBL] [Abstract][Full Text] [Related]
37. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.
Camicioli RM; Korzan JR; Foster SL; Fisher NJ; Emery DJ; Bastos AC; Hanstock CC
Neurosci Lett; 2004 Jan; 354(3):177-80. PubMed ID: 14700725
[TBL] [Abstract][Full Text] [Related]
38. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla.
Oeltzschner G; Wijtenburg SA; Mikkelsen M; Edden RAE; Barker PB; Joo JH; Leoutsakos JS; Rowland LM; Workman CI; Smith GS
Neurobiol Aging; 2019 Jan; 73():211-218. PubMed ID: 30390554
[TBL] [Abstract][Full Text] [Related]
39. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
Catani M; Mecocci P; Tarducci R; Howard R; Pelliccioli GP; Mariani E; Metastasio A; Benedetti C; Senin U; Cherubini A
J Am Geriatr Soc; 2002 Oct; 50(10):1707-10. PubMed ID: 12366626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
